Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Authors
Keywords
-
Journal
CANCER TREATMENT REVIEWS
Volume 120, Issue -, Pages 102629
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.ctrv.2023.102629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
- (2023) Farhad Seif et al. Molecular Therapy-Oncolytics
- Updated Immunotherapy for Gastric Cancer
- (2023) Yukiya Narita et al. Journal of Clinical Medicine
- KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
- (2023) Heikki Joensuu Cancers
- Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
- (2022) Verena Schlintl et al. BMC CANCER
- Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
- (2022) Yoon-Koo Kang et al. LANCET ONCOLOGY
- CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
- (2022) Yujiro Kidani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
- (2022) Diwakar Davar et al. CLINICAL CANCER RESEARCH
- Immunotherapy of Cancer by Targeting Regulatory T cells
- (2022) Bo-Jin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
- (2022) Yan Tie et al. Journal of Hematology & Oncology
- Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
- (2022) Kohei Shitara et al. NATURE
- Epidemiology of stomach cancer
- (2022) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling
- (2022) Shu Shien Chin et al. Nature Communications
- Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells
- (2022) David Noyes et al. Journal for ImmunoTherapy of Cancer
- Impact of Lipid Metabolism on Antitumor Immune Response
- (2022) Nesrine Mabrouk et al. Cancers
- Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
- (2022) Megan M Y Hong et al. Cancers
- Immunosuppressive Signaling Pathways as Targeted Cancer Therapies
- (2022) Botle Precious Setlai et al. Biomedicines
- Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
- (2022) Pratibha Pandey et al. Pharmaceuticals
- Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma
- (2022) Wei Wang et al. Gastric Cancer
- Human FOXP3 and tumour microenvironment
- (2022) Jia Wang et al. IMMUNOLOGY
- Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
- (2022) Yuheng Yan et al. Journal of Hematology & Oncology
- NF-κB in control of regulatory T cell development, identity, and function
- (2022) Nadine Hövelmeyer et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
- (2022) Yefang Lao et al. Cancers
- The Roles of Immune Cells in Gastric Cancer: Anti-Cancer or Pro-Cancer?
- (2022) Asif Sukri et al. Cancers
- Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2022) Xavier Thuru et al. Cancers
- Predictive biomarkers in gastric cancer
- (2022) C. Röcken JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation
- (2022) Alan Kennedy et al. NATURE IMMUNOLOGY
- Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
- (2022) Bayley R. McRitchie et al. Frontiers in Immunology
- First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors
- (2022) Omid Hamid et al. Journal for ImmunoTherapy of Cancer
- Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics
- (2022) Mitesh Dwivedi et al. Heliyon
- CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
- (2022) Joanna Bogacka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism
- (2022) Sanyog Dwivedi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EBV and MSI Status in Gastric Cancer: Does It Matter?
- (2022) Catarina Neto do Nascimento et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Key chemokines direct migration of immune cells in solid tumors
- (2021) Karan Kohli et al. CANCER GENE THERAPY
- Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
- (2021) Rebekka Duhen et al. Nature Communications
- Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer
- (2021) Ming Lei et al. CLINICAL CANCER RESEARCH
- PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
- (2021) Rosalin Mishra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy
- (2021) Marco Gargaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Next generation of immune checkpoint inhibitors and beyond
- (2021) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer
- (2021) Sonia Trombino et al. MOLECULES
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- (2021) Ronan J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
- (2021) Justine Cinier et al. Cancers
- The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
- (2021) Christiana M. Neophytou et al. Cancers
- Endoscopic screening for gastric cancer in Japan: Current status and future perspectives
- (2021) Katsuhiro Mabe et al. Digestive Endoscopy
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle
- (2021) Aikaterini Hatzioannou et al. Frontiers in Immunology
- Global Incidence and Mortality of Gastric Cancer, 1980-2018
- (2021) Martin C. S. Wong et al. JAMA Network Open
- Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients
- (2021) Hyun Cheol Chung et al. CANCER
- Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade
- (2021) Michael L. Dixon et al. Molecular Cancer
- The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
- (2021) Yelena Y. Janjigian et al. NATURE
- Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy
- (2021) Galina Zhulai et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Pan-cancer single-cell landscape of tumor-infiltrating T cells
- (2021) Liangtao Zheng et al. SCIENCE
- Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation
- (2021) Alexandra Lainé et al. Nature Communications
- Survival outcomes of management in metastatic gastric adenocarcinoma patients
- (2021) Huang-Ming Hu et al. Scientific Reports
- Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity
- (2021) Deyong Song et al. Scientific Reports
- Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity
- (2021) Kazuhiko Matsuo et al. Cancers
- Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway
- (2020) Hui Zhong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
- (2020) Qianru Huang et al. Journal of Genetics and Genomics
- PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
- (2020) Yujun Park et al. Cancer Research and Treatment
- Treg Heterogeneity, Function, and Homeostasis
- (2020) Daniil Shevyrev et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody
- (2020) Hirofumi Ohmura et al. BRITISH JOURNAL OF CANCER
- The Complexity of Targeting Chemokines to Promote a Tumor Immune Response
- (2020) Marianne Strazza et al. INFLAMMATION
- Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen ( RADPAC )
- (2020) Sylvie Lorenzen et al. INTERNATIONAL JOURNAL OF CANCER
- Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
- (2020) Shota Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population
- (2020) Qiang Wang et al. Molecular Medicine Reports
- Memory T cells: strategies for optimizing tumor immunotherapy
- (2020) Qingjun Liu et al. Protein & Cell
- Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
- (2020) Chunxiao Li et al. Molecular Cancer
- Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
- (2020) Jackie E. Bader et al. MOLECULAR CELL
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Regulatory t cell metabolism at the intersection between autoimmune diseases and cancer
- (2020) Henry Kurniawan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
- (2020) Shogo Kumagai et al. NATURE IMMUNOLOGY
- ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models
- (2020) Amanda Hanson et al. PLoS One
- ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
- (2020) Dan-Yang Li et al. Frontiers in Immunology
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy
- (2020) Sundee Dees et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TIM-3 pathway dysregulation and targeting in cancer
- (2020) Amer M Zeidan et al. Expert Review of Anticancer Therapy
- T cell Tolerance in Early Life
- (2020) Lijun Yang et al. Frontiers in Immunology
- Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
- (2019) Prabhakaran Kumar et al. SEMINARS IN CANCER BIOLOGY
- Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
- (2019) James B. Wing et al. IMMUNITY
- Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
- (2019) Yung-Jue Bang et al. Gastric Cancer
- Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
- (2019) Deepali V. Sawant et al. NATURE IMMUNOLOGY
- Rational design of anti-GITR-based combination immunotherapy
- (2019) Roberta Zappasodi et al. NATURE MEDICINE
- Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance
- (2019) Simon Pernot et al. Gastric Cancer
- Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies
- (2019) Xu Liu et al. Journal of Translational Medicine
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
- (2019) Atsushi Tanaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers
- (2018) Lesley J. Scott DRUGS
- Biology of IL-2 and its therapeutic modulation: Mechanisms and strategies
- (2018) Suman Mitra et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- Regulatory T cells in autoimmune disease
- (2018) Margarita Dominguez-Villar et al. NATURE IMMUNOLOGY
- Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression
- (2018) Paula Díaz et al. Frontiers in Microbiology
- Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
- (2018) Benoît L. Salomon et al. Frontiers in Immunology
- Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-γ in peripheral blood
- (2018) Na Li et al. Cancer Biomarkers
- CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
- (2018) Yelena Y. Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- 1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1
- (2018) A Hansen et al. ANNALS OF ONCOLOGY
- Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
- (2018) Elena Gianchecchi et al. Frontiers in Immunology
- Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
- (2018) Yasuko Tada et al. Journal for ImmunoTherapy of Cancer
- Immunoregulatory functions of VISTA
- (2017) Elizabeth C. Nowak et al. IMMUNOLOGICAL REVIEWS
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- The role and significance of VEGFR2+ regulatory T cells in tumor immunity
- (2017) Panrong Zhu et al. OncoTargets and Therapy
- Increased tumor-infiltrating CD45RA−CCR7− regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress
- (2017) Fang-yuan Mao et al. Cell Death & Disease
- Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA
- (2017) Yuan Tian et al. Nature Communications
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β
- (2016) Bert Kindlund et al. Gastric Cancer
- ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
- (2016) Hirotsugu Nagase et al. INTERNATIONAL JOURNAL OF CANCER
- Lauren classification and individualized chemotherapy in gastric cancer
- (2016) JUNLI MA et al. Oncology Letters
- Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation
- (2016) Asiel Arce-Sillas et al. Journal of Immunology Research
- Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
- (2015) Christopher A. Fuhrman et al. JOURNAL OF IMMUNOLOGY
- Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells
- (2015) Simona Ronchetti et al. Journal of Immunology Research
- Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model
- (2015) De-Kuan Chang et al. OncoImmunology
- VISTA Regulates the Development of Protective Antitumor Immunity
- (2014) I. Le Mercier et al. CANCER RESEARCH
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
- (2014) Nicole Joller et al. IMMUNITY
- The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
- (2014) Bob Yang et al. MEDIATORS OF INFLAMMATION
- Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value
- (2014) Felix Berlth WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
- (2013) Kyung-Ju Kim et al. HUMAN PATHOLOGY
- Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen andHelicobacter pyloriantibody titer
- (2013) Takeichi Yoshida et al. INTERNATIONAL JOURNAL OF CANCER
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- CCR7 Expression and Intratumoral FOXP3+ Regulatory T Cells are Correlated with Overall Survival and Lymph Node Metastasis in Gastric Cancer
- (2013) Shuang Zhou et al. PLoS One
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- Regulation of Adaptive Immunity; The Role of Interleukin-10
- (2013) T. H. Sky Ng et al. Frontiers in Immunology
- TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
- (2013) Kaori Sakuishi et al. OncoImmunology
- T Cells in Gastric Cancer: Friends or Foes
- (2012) Amedeo Amedei et al. Clinical & Developmental Immunology
- The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
- (2011) S. Amarnath et al. Science Translational Medicine
- Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer
- (2010) Bangwei Cao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2
- (2009) T. Okamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
- (2008) Yoshiki Mizukami et al. INTERNATIONAL JOURNAL OF CANCER
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started